International Clinical Trial: Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519005) titled 'Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure' on April 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Xijing Hospital

Condition: Hepatic Failure

Intervention: Biological: Ex vivo perfusion of six-gene-edited porcine liver

Recruitment Status: Not recruiting

Phase: Early Phase 1

Date of First Enrollment: January 31, 2026

Target Sample Size: 1

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT0...